Rejuvenation
13
1
2
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
7.7%
1 terminated out of 13 trials
87.5%
+1.0% vs benchmark
8%
1 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (13)
Secretome Treatment for Facial Rejuvenation
Comparative Effects Of Trichloroacetic Chemical Peel And Fractional Laser
Efficacy and Safety of a Novel Monopolar Radiofrequency Device for Mid and Lower Face Rejuvenation
Energy Devices for Rejuvenation
Consensus on Skin Care in Breast Cancer Patients
Expert Consensus on the Use of Isotretinoin in Rejuvenation: A Delphi Study
MENA Consensus on Poly-L-Lactic Acid (PLLA) Biostimulator Use in Aesthetic Dermatology
A Prospective Evaluation of Infraorbital Filler Injection
Study of a Novel Laser for Skin Rejuvenation
Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles
The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment
Microbotox for Lower Face Rejuvenation
Evaluation of Non-ablative and Fractional Combination Treatment for Improvement in Skin's Appearance